AMYLIN PHARMACEUTICALS INC: capex

Value{"amount": 21502000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2012-01-01 – 2012-06-30
Statuscurrent
EntityAMYLIN PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000881464-12-000017 · Open the official SEC filing →
Retrieved: 2026-08-19T08:48:02.716993+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000881464/capex/2012-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/13821fcd-8fde-4622-a89f-25e1d64ed3a7

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies